Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study
Open Access
- 1 January 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (1), 105-108
- https://doi.org/10.1023/a:1008200825886
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.Journal of Clinical Oncology, 1997
- Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidinesAnnals of Oncology, 1996
- CPT-11 (Irinotecan) in the treatment of colorectal cancerEuropean Journal Of Cancer, 1995
- Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rateEuropean Journal Of Cancer, 1993
- The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.Journal of Clinical Oncology, 1993
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.Journal of Clinical Oncology, 1990
- Phase I study of oxaliplatin in patients with advanced cancerCancer Chemotherapy and Pharmacology, 1990
- Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental dataBiomedicine & Pharmacotherapy, 1989